文献
J-GLOBAL ID:202102250591120477
整理番号:21A0075228
エピジェネティックプローブとしての選択的HDAC/BRD4二重阻害剤の発見【JST・京大機械翻訳】
Discovery of selective HDAC/BRD4 dual inhibitors as epigenetic probes
著者 (19件):
Chen Jingjing
(State Key Laboratory of Drug Research, Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 ZuChongZhi Road, Shanghai, 201203, China)
,
Chen Jingjing
(University of Chinese Academy of Sciences, 19 Yuquan Road, Beijing, 110039, China)
,
Li Yalei
(Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Rd, Shanghai, 201203, China)
,
Zhang Jie
(State Key Laboratory of Drug Research, Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 ZuChongZhi Road, Shanghai, 201203, China)
,
Zhang Jie
(University of Chinese Academy of Sciences, 19 Yuquan Road, Beijing, 110039, China)
,
Zhang Minmin
(Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Rd, Shanghai, 201203, China)
,
Wei Aihuan
(State Key Laboratory of Drug Research, Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 ZuChongZhi Road, Shanghai, 201203, China)
,
Liu Hongchun
(Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Rd, Shanghai, 201203, China)
,
Xie Zhicheng
(State Key Laboratory of Drug Research, Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 ZuChongZhi Road, Shanghai, 201203, China)
,
Xie Zhicheng
(University of Chinese Academy of Sciences, 19 Yuquan Road, Beijing, 110039, China)
,
Ren Wenming
(State Key Laboratory of Drug Research, Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 ZuChongZhi Road, Shanghai, 201203, China)
,
Duan Wenwen
(State Key Laboratory of Drug Research, Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 ZuChongZhi Road, Shanghai, 201203, China)
,
Zhang Zhuo
(State Key Laboratory of Drug Research, Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 ZuChongZhi Road, Shanghai, 201203, China)
,
Zhang Zhuo
(University of Chinese Academy of Sciences, 19 Yuquan Road, Beijing, 110039, China)
,
Shen Aijun
(Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Rd, Shanghai, 201203, China)
,
Shen Aijun
(University of Chinese Academy of Sciences, 19 Yuquan Road, Beijing, 110039, China)
,
Hu Youhong
(State Key Laboratory of Drug Research, Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 ZuChongZhi Road, Shanghai, 201203, China)
,
Hu Youhong
(University of Chinese Academy of Sciences, 19 Yuquan Road, Beijing, 110039, China)
,
Hu Youhong
(School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, UCAS, Hangzhou, 310024, China)
資料名:
European Journal of Medicinal Chemistry
(European Journal of Medicinal Chemistry)
巻:
209
ページ:
Null
発行年:
2021年
JST資料番号:
E0845A
ISSN:
0223-5234
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)